Last updated: July 12, 2026
Plain-language summary (not a substitute for the full terms below): VitalQuant is a research publisher, not an investment advisor. Our content is educational and impersonal—it is not personalized advice, and you are solely responsible for your investment decisions and any resulting gains or losses. Past results are not necessarily indicative of future results. The full terms below govern.
All content on this website and in VitalQuant’s subscriber materials — including strategy signals, weekly reports, articles, white papers, research, analyses, methodologies, text, and graphics, as well as the Vital Risk Control™ system — is the property of Vital Quantitative Research, LLC and is protected by United States and international copyright, trademark, and other intellectual property laws. “VitalQuant” and “Vital Risk Control” are trademarks of Vital Quantitative Research, LLC.
Your subscription grants you a limited, personal, non-exclusive, non-transferable license to access and use our content solely for your own individual investing purposes. You may not copy, reproduce, republish, distribute, display, sell, resell, sublicense, or otherwise share our content — including strategy signals and reports — with any non-subscriber, or use it for any commercial purpose, without our prior written consent.
Please understand that we are happy to have our content quoted, as long as we have granted permission to legitimate investment-content resource providers following your written request. In return, we only ask for a basic link-back attribution tag that references the content’s origin.
We actively protect our intellectual property. Unauthorized use or distribution of our content may result in immediate termination of your subscription without refund. It may expose you to civil liability, including statutory damages of up to $150,000 per infringed work for willful infringement under the U.S. Copyright Act (17 U.S.C. § 504), together with injunctive relief and recovery of costs and attorneys’ fees. Willful infringement carried out for commercial advantage or private financial gain may also carry criminal penalties under federal law.
We reserve all rights not expressly granted.
All content herein is issued solely for informational purposes to demonstrate the effectiveness of systematic investment strategies, and is not to be construed as an offer to sell or the solicitation of an offer to buy, nor should it be interpreted as a recommendation to buy, hold, or sell (short or otherwise) any security. The information is provided with the understanding that Vital Quantitative Research, LLC and VitalQuant.com are not acting in a fiduciary capacity and we offer no individual investment advice.
VitalQuant.com does not know any user’s specific investment objectives, financial situation, or the needs of any particular person who may view this material, nor may the investments discussed herein be suitable for all types of investors. It is your responsibility to determine if the approach of a particular strategy is right for you, or if none of the strategies are appropriate for your needs.
While VitalQuant.com undertakes significant effort to ensure that all opinions, analyses, and information included herein are based on sources believed to be reliable, no representation or warranty of any kind, expressed or implied, is made, including but not limited to any representation or warranty concerning accuracy, completeness, correctness, fitness, timeliness, or appropriateness.
Additionally, VitalQuant undertakes no obligation to update previously published opinions, analyses, or information provided, should conditions change. You should independently verify all information obtained.
You can access the Member’s Area of our website and try the various products we offer at no cost during your 14-day Free Trial. If you are interested in multiple products, you should sign up for each of them at the beginning of your Free Trial. The 14-day Free Trial policy applies once per user. Additional 14-day Free Trials are not available after you use the initial 14-day trial, regardless of the products selected. In other words, free trials are user-based, not product-based.
Our 60-Day Satisfaction Guarantee applies to all premium subscriptions from the first day of a paid subscription through the 60th day of that subscription. Just let us know you'd like a refund, and we will cancel your subscription and promptly return your payment. The 60-day Satisfaction Guarantee is available one time per user. After the 60th day, you can cancel your subscription at any time, and you will never be charged again.
If you are not sure if stocks, exchange-traded funds, algorithmic/rules-based investing, or a particular investment approach is right for you, or if investment or other professional advice is required, we urge you to consult with a Registered Investment Advisor (RIA). Neither this website nor anyone associated with producing its content represents themselves to be Registered Investment Advisors, and we do not attempt to substitute for personalized, professional investment advice. Please get in touch with the appropriate professional if you need that assistance, whether it be an Accountant, Attorney, Registered Investment Advisor, or other professional.
Strategy contributors must have prior professional experience at recognized investment banks, hedge funds, asset managers, or quantitative research firms. Employer names are shown only when verified and requested by the strategy contributor; no bank or fund mentioned on the site endorses VitalQuant or any particular strategy unless clearly stated otherwise. The listing of various banks and funds in the information materials is to show the backgrounds of existing strategy designers and to indicate the caliber of professionalism we seek in the firms from which we recruit strategy designers.
Some of the VitalQuant.com content may include results and analysis obtained from backtesting trading algorithms on historical data. Please note that hypothetical or simulated performance results have certain limitations. Unlike an actual performance record, simulated results do not reflect actual trading, as prices are set at the time of each trade. Also, since actual individual investors have not executed the trades, the results may have under- or overcompensated for the impact, if any, of certain market factors such as liquidity.
Each Premium Strategy published by VitalQuant has been tracked live, out-of-sample, for a minimum of five years, and some for far longer. Where a strategy’s displayed performance history extends earlier than its live-tracking start date, that earlier portion reflects backtested (hypothetical) results, as described above. We provide the date live tracking began in each strategy’s profile, so you can see which portion of the displayed history is live and which is backtested.
Vital Quantitative Research, LLC, dba VitalQuant.com, makes no representation that any particular equity or strategy will or is likely to achieve profits or losses similar to those represented by the Premium Strategy previews herein. Past performance is not necessarily indicative of future performance. Future live conditions can change from the documented live conditions of a systematic strategy in ways a model cannot anticipate. Examples include major wars, hyperinflation, political upheaval, and many other geopolitical events that can significantly affect the pricing of ownership in publicly traded equities.
To establish a fair price for transactions, we use a calculation that divides the day’s High, Low, and 2x Closing price by 4. The prices recorded for these transactions are as accurate as possible, but occasionally a significantly errant price slips through the various exchanges and our data providers. If you notice an incorrect quoted price, please get in touch with us, and we will follow up with our data providers to correct the error.
Each week, VitalQuant makes every effort to ensure the transaction prices recorded for a Premium Strategy are as accurate as possible. We recognize that the prices investors get can vary widely depending on the time of day and their brokers’ trading efficiency. Our approach is, in our judgment, as fair as possible until a better system is developed.
We calculate the Max Drawdown statistic as follows. Our software looks at the equity chart of the system in question and finds the largest percentage decline from a local “peak” to a subsequent point in time (formally called “Maximum Peak to Trough Drawdown”). While this is useful when evaluating trading systems, keep in mind that past performance does not guarantee future results. Therefore, future drawdowns may be larger or smaller than the historical maximum drawdowns you see in a strategy profile.
In addition to the “Max Drawdown” for a strategy since launch, we also calculate and often use the “Average Annual Maximum Drawdown (AAMD)” in our documentation and discussions. This calculation measures a model’s Max Drawdown for each calendar year, sums them, and then averages them across a strategy’s life.
As a simple example, a strategy with only three years of performance tracking has a Max Drawdown in year 1 of -10%, a Max Drawdown in year 2 of -12%, and a Max Drawdown in year 3 of -8%. Therefore, the strategy’s AAMD is -10% (8 + 12 + 8 = 30 / 3 = -10%). Many subscribers believe that Average Annual Maximum Drawdown is a more representative estimate of a strategy’s ongoing risk than focusing on the Max Drawdown alone. Therefore, we provide both figures to readers, subscribers, and researchers.
Equity investing is inherently risky, and you may lose some or all of the money you invest in stocks or ETFs. While losing your entire investment is exceptionally rare and would require a business to file for bankruptcy, we disclose these risks well in advance, and it is highly unlikely that any of our quantitative strategies would select such a company or ETF for investment. Nevertheless, while we do our best to avoid significant loss, you should always keep in mind that losses are possible with any investment strategy.
Neither VitalQuant.com nor its employees, service providers, associates, strategy designers, or affiliates are responsible for any losses you may incur as a result of using the information provided. You should not invest any money you cannot afford to lose in part or in its entirety.
Vital Quantitative Research, LLC makes every effort to keep the information we receive from you private. This information includes your name, email address, and estimated portfolio size. When you join, you provide your credit card or bank information, but VitalQuant does not see or have access to it. Stripe, Inc., our payment processor, processes your payment details; Outseta is the platform we use to manage your account, subscription, and billing.
We use your estimated portfolio size solely to control the amount of capital directed to portfolio equities, so that our subscribers do not affect position prices. We don't use this information for any other purpose.
For full details on what we collect and how we handle it, see our Privacy Policy.
We reserve the right to restrict or terminate access to the website for users who violate these terms, misuse the platform, or engage in any abusive behavior toward the website’s administrators, as determined by the administrators.
Vital Quantitative Research, LLC, 48 Wall Street, Suite 1100, New York, NY 10005.
If you have any questions or comments regarding these Terms and Conditions, please get in touch with us via a Support Ticket using the link below.
© Vital Quantitative Research, LLC • All rights reserved
VitalQuant provides individual investors with high-performance, institutional-grade investment strategy signals at an affordable price. Profit from models designed by Wall Street strategists today.
.svg)
.svg)
.svg)
© Vital Quantitative Research, LLC • All rights reserved
